RxDoctor Payments Data

Renata Moen, APRN

Family · Jacksonville, FLNPI 1417494840

Payments from drug & device makers

$13,471in general payments, 2019–2025

Across 586 payments — averaging $22.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • GSK$914
  • Boehringer Ingelheim$825
  • Regeneron Healthcare Solutions, Inc.$818
  • Takeda Pharmaceuticals U.S.A., Inc.$710
  • Actelion Pharmaceuticals US, Inc.$666
  • plus $7K from 53 others

What the payments were for

  • Food & beverage$13,20298%
  • Education$2692%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca108$2,422
GSK46$914
Boehringer Ingelheim37$825
Regeneron Healthcare Solutions, Inc.27$818
Takeda Pharmaceuticals U.S.A., Inc.35$710
Actelion Pharmaceuticals US, Inc.23$666
Inspire Medical Systems, Inc.3$624
AbbVie35$611
United Therapeutics Corporation22$500
ANI Pharmaceuticals, Inc.19$460
Sanofi16$404
Merck17$394
Novartis21$353
Amgen14$300
Mallinckrodt Hospital Products Inc.14$298
Insmed, Inc.11$286
Axsome Therapeutics, Inc.10$239
Jazz Pharmaceuticals Inc.9$227
Grifols USA, LLC10$212
Shionogi Inc11$209
Viatris Specialty LLC8$206
Inogen, Inc.9$205
Alnylam Pharmaceuticals Inc.2$145
Genentech USA, Inc.5$112
UCB, Inc.6$105
Mylan Specialty L.p.4$101
Teva Pharmaceuticals USA, Inc.6$98
SK Life Science, Inc.5$95
Amneal Pharmaceuticals LLC6$87
Electromed, Inc.4$86
Lilly USA, LLC4$74
Neurocrine Biosciences, Inc.3$52
EMD Serono, Inc.3$52
Abbott2$47
Baxter Healthcare3$43
CSL Behring2$40
Idorsia Pharmaceuticals US Inc2$38
Johnson & Johnson2$35
Supernus Pharmaceuticals, Inc.2$33
Avanir Pharmaceuticals, Inc.1$23
Avadel CNS Pharmaceuticals, LLC1$22
Pulmonx Corporation1$20
Vifor Pharma, Inc.1$20
Otsuka America Pharmaceutical, Inc.1$20
Acadia Pharmaceuticals Inc1$19
Biohaven Pharmaceuticals, Inc.1$19
MDD US Operations, LLC1$18
Eisai Inc.1$18
Harmony Biosciences LLC1$17
Bayer1$17
Livanova USA, Inc.1$17
Sanofi-aventis U.S. LLC1$16
Tactile Systems Technology Inc1$16
Adamas Pharmaceuticals, Inc.1$16
Paratek Pharmaceuticals, Inc.1$15
Pfizer1$15
Acorda Therapeutics, Inc1$15
Tanabe Pharma America, Inc.1$13
Arbor Pharmaceuticals, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,471 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$119,156
Medicare patients
738
Services billed
1,933

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter139$122,830
Breztri AerosphereBudesonide/Glycopyr/Formoterol82$69,905
Advair HfaFluticasone Propion/Salmeterol51$19,131
Breo ElliptaFluticasone/Vilanterol37$15,701
Stiolto RespimatTiotropium Br/Olodaterol Hcl14$12,152
Spiriva RespimatTiotropium Bromide13$7,709
Incruse ElliptaUmeclidinium Bromide19$6,616
SymbicortBudesonide/Formoterol Fumarate18$4,052
Albuterol Sulfate HfaAlbuterol Sulfate164$3,701
Wixela InhubFluticasone Propion/Salmeterol25$2,431
Ventolin HfaAlbuterol Sulfate27$1,569
Zaleplon12$1,290
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$1,012
Montelukast Sodium96$993
Azithromycin127$931

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$914$145,147195 claims
AstraZenecaBreztri Aerosphere, Symbicort$2,422$73,958100 claims
Boehringer IngelheimStiolto Respimat, Spiriva Respimat$825$19,86127 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.

Other family in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →